Corinne Duguet

798 total citations
7 papers, 530 citations indexed

About

Corinne Duguet is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, Corinne Duguet has authored 7 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Corinne Duguet's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Synthesis and Biological Activity (3 papers). Corinne Duguet is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Synthesis and Biological Activity (3 papers). Corinne Duguet collaborates with scholars based in France and Canada. Corinne Duguet's co-authors include J. Revuz, J Latarjet, L Vaillant, Hélène Bocquet, P. Wolkenstein, A. Pilorget, Jean‐Claude Roujeau, B. Milpied, Christian Brun‐Buisson and S. Ochonisky and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Investigative Dermatology.

In The Last Decade

Corinne Duguet

6 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corinne Duguet France 6 223 207 154 139 134 7 530
Kenneth Washenik United States 5 132 0.6× 22 0.1× 64 0.4× 69 0.5× 47 0.4× 7 409
Ding‐Ping Chen Taiwan 11 150 0.7× 70 0.3× 39 0.3× 71 0.5× 48 0.4× 54 403
M J Grange France 6 115 0.5× 127 0.6× 84 0.5× 18 0.1× 111 0.8× 11 327
Rod Kunynetz Canada 9 176 0.8× 10 0.0× 249 1.6× 48 0.3× 69 0.5× 11 661
Eric Helmer Belgium 8 68 0.3× 12 0.1× 117 0.8× 64 0.5× 49 0.4× 18 497
L.L.A. Lecluse Netherlands 9 49 0.2× 26 0.1× 120 0.8× 31 0.2× 75 0.6× 10 600
Anabela Cardoso United States 8 117 0.5× 10 0.0× 268 1.7× 38 0.3× 46 0.3× 18 481
V. Rodriguez United States 8 118 0.5× 25 0.1× 17 0.1× 60 0.4× 44 0.3× 18 395
Vladimı́r Vašků Czechia 12 36 0.2× 15 0.1× 58 0.4× 57 0.4× 55 0.4× 50 418
Д. Е. Каратеев Russia 11 147 0.7× 20 0.1× 436 2.8× 56 0.4× 36 0.3× 174 667

Countries citing papers authored by Corinne Duguet

Since Specialization
Citations

This map shows the geographic impact of Corinne Duguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Duguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Duguet more than expected).

Fields of papers citing papers by Corinne Duguet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Duguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Duguet. The network helps show where Corinne Duguet may publish in the future.

Co-authorship network of co-authors of Corinne Duguet

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Duguet. A scholar is included among the top collaborators of Corinne Duguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Duguet. Corinne Duguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Grosbois, B., Éric Bellissant, Philippe Moreau, et al.. (2003). O95 Treatment of advanced multiple myeloma (MM) with thalidomide (THAL). Long term follow-up in a prospective study of 121 patients. European Journal of Internal Medicine. 14. S27–S28. 5 indexed citations
3.
Bastuji‐Garin, Sylvie, S. Ochonisky, P. Bouché, et al.. (2002). Incidence and Risk Factors for Thalidomide Neuropathy: a Prospective Study of 135 Dermatologic Patients. Journal of Investigative Dermatology. 119(5). 1020–1026. 119 indexed citations
4.
Yakoub‐Agha, Ibrahim, Michel Attal, Charles Dumontet, et al.. (2002). Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM). The Hematology Journal. 3(4). 185–192. 65 indexed citations
5.
Yakoub‐Agha, Ibrahim, Philippe Moreau, Serge Leyvraz, et al.. (2000). Thalidomide in patients with advanced multiple myeloma. The Hematology Journal. 1(3). 186–189. 37 indexed citations
6.
Wolkenstein, P., J Latarjet, Jean‐Claude Roujeau, et al.. (1998). Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. The Lancet. 352(9140). 1586–1589. 276 indexed citations
7.
Wolkenstein, P., Corinne Duguet, L. Vaillant, et al.. (1998). Randomized double-blind comparison of thalidomide versus placebo in toxic epidermal necrolysis : Overmortality in treated group. Journal of Dermatological Science. 16. S44–S44.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026